Vaccinex, Inc. (VCNX)
NASDAQ: VCNX · IEX Real-Time Price · USD
7.21
+0.11 (1.55%)
Jul 22, 2024, 10:16 AM EDT - Market open
Vaccinex Employees
As of December 31, 2023, Vaccinex had 40 total employees, including 37 full-time and 3 part-time employees. The number of employees decreased by 3 or -6.98% compared to the previous year.
Employees
40
Change (1Y)
-3
Growth (1Y)
-6.98%
Revenue / Employee
$3,100
Profits / Employee
-$479,650
Market Cap
11.40M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Mustang Bio | 80 |
RedHill Biopharma | 53 |
Senti Biosciences | 48 |
Calidi Biotherapeutics | 41 |
Imunon | 33 |
Dominari Holdings | 28 |
Traws Pharma | 18 |
BioRestorative Therapies | 11 |
VCNX News
- 6 weeks ago - Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer's Disease - GlobeNewsWire
- 2 months ago - Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Vaccinex Reports 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 5 months ago - Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology - GlobeNewsWire
- 5 months ago - Vaccinex, Inc. Announces Reverse Stock Split - GlobeNewsWire
- 5 months ago - Vaccinex Announces Pricing of $3.7 Million PIPE Financing - GlobeNewsWire
- 8 months ago - Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule - GlobeNewsWire